Liver-specific knockout of fatty acid synthase (FAS), an enzyme catalyzing the synthesis of FA, results in NASH which could be reversed by PPARα agonists, identifying products of FAS as PPARα activators (42), which further reported phospholipid as a FAS-dependent lipid intermediate PPARα ligand. Here, PPARA is linked to metabolic dysfunction-associated steatohepatitis.